With Test Program, Cabinet Aims to Force Generic Drug Industry to Raise Bar

(Beijing) – Yellow lights are flashing on what's been an easy road to generic drug sales now that the government has introduced a pharmaceuticals assessment project.

Thousands of generics makers in a health care industry niche with annual revenues of nearly 500 billion yuan soon may be heeding a government call to join a "conformity assessment" project that runs through 2018.